Completed NCT00211250
This summary needs review. Please check the official study record and contact the research team for details.
In Joliet Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug i A study involving a medication or substance. Over 18 Years
Countries United States
Sponsor Joliet Center for Clinical Research
Condition Bipolarity Completed NCT00845507
This summary needs review. Please check the official study record and contact the research team for details.
In Cincinnati Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 55 Years
Countries United States
Sponsor University of Cincinnati
Condition Bipolarity Unknown NCT06616337
This summary needs review. Please check the official study record and contact the research team for details.
In Strasbourg Why is this study shown? This study is directly about Bipolarity.
Bipolarity Observational i A study where researchers collect information without assigning a treatment. Over 18 Years
Countries France
Sponsor University Hospital, Strasbourg, France
Condition Bipolarity Completed NCT01014416
This summary needs review. Please check the official study record and contact the research team for details.
In Seoul Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 20 Years to 45 Years
Countries South Korea
Sponsor Korea Otsuka Pharmaceutical Co., Ltd.
Condition Bipolarity Completed NCT01062607
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Salzburg Why is this study shown? This study is directly about Bipolarity.
Bipolarity Observational Over 18 Years
Countries France, Belgium, Austria, ...
Sponsor AstraZeneca
Condition Bipolarity Completed NCT02184767
This study is completed in the United States. 5, 5, or 10 mg for Bipolarity.
Multiple locations, including Atlanta Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 10 Years to 17 Years
Countries United States
Sponsor Teva Branded Pharmaceutical Products R&D, Inc.
Condition Bipolarity Terminated EUCTR 2016-001714-14
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Italy Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug
Countries Italy
Sponsor AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.
Condition Bipolarity Completed EUCTR 2007-001442-41
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Italy Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug
Countries Italy
Sponsor AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
Condition Bipolarity Completed NCT03383874
This summary needs review. Please check the official study record and contact the research team for details.
In Dallas Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States
Sponsor University of Texas Southwestern Medical Center
Condition Bipolarity Terminated NCT00767715
This summary needs review. Please check the official study record and contact the research team for details.
In Danderyd Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 60 Years
Countries Sweden
Sponsor Eli Lilly and Company
Condition Bipolarity Completed NCT03207048
This study is completed in China. It is testing repetitive Transcranial Magnetic Stimulation for Bipolarity.
In Guangzhou Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 18 Years to 60 Years
Countries China
Sponsor Guangzhou Psychiatric Hospital
Condition Bipolarity Completed NCT00132678
This study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States, Austria, India, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Bipolarity